Clinical Trial Update: of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

View source ↗

Summary

A completed clinical trial update from AstraZeneca on patient education related to cardiovascular risk factors in type 2 diabetes, focusing on achieving LDL cho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Low Density Lipoprotein Cholesterol Goal Achievement | Status: COMPLETED